Screening for tuberculosis before TNFα antagonist initiation: Are current methods good enough?

Joint Bone Spine

Volumn 75, Issue 2, 2008, Pages 112-115

  Bergeron, Anne ^a   Herrmann, Jean Louis ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; TUBERCULOSTATIC AGENT; BACTERIUM ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

DERMATOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EDITORIAL; GASTROENTEROLOGY; HUMAN; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NURSE; PHYSICIAN; PRIMARY TUBERCULOSIS; RHEUMATOLOGY; SCREENING; TUBERCULIN TEST; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; METABOLISM; TUBERCULOSIS;

ANTIBODIES, BACTERIAL; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41049098640     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.09.005     Document Type: Editorial

References (26)

1. Kaufmann S.H., and McMichael A.J. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11 (2005) S33-S44
2. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20 (2002) 581-620
3. Wallis R.S., Broder M.S., Wong J.Y., et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38 (2004) 1261-1265
4. Russell D.G. Who puts the tubercle in tuberculosis?. Nat Rev Microbio 5 (2007) 39-47
5. Herrmann J.L., Tailleux L., Nigou J., et al. Le rôle des cellules dendritiques humaines dans la tuberculose: protecteur ou non protecteur?. Rev Mal Respir 23 (2006) 6S21-6S28
6. Kaufmann S.H., and Schaible U.E. A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J Exp Med 197 (2003) 1-5
7. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129
8. Young D., Hussell T., and Dougan G. Chronic bacterial infections: living with unwanted guests. Nat Immunol 3 (2002) 1026-1032
9. Arriaga A.K., Orozco E.H., Aguilar L.D., et al. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol 128 (2002) 229-237
10. Plessner H.L., Lin P.L., Kohno T., et al. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. J Infect Dis 195 (2007) 1643-1650
11. Keane J., Gershon S., Wise R.P., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 (2001) 1098-1104
12. Wolfe F., Michaud K., Anderson J., et al. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50 (2004) 372-379
13. Gómez-Reino J.J., Carmona L., Valverde V.R., et al., BIOBADASER Group. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48 (2003) 2122-2127
14. Bearman J.E., Kleinman H., Glyer V.V., et al. A study of variability in tuberculin test reading. Am Rev Respir Dis 90 (1964) 913-919
15. Lagrange P.H., Simonney N., and Herrmann J.L. New immunological tests in the diagnosis of tuberculosis. Rev Mal Respir 24 (2007) 453-472
16. Andersen P., Munk M.E., Pollock J.M., et al. Specific immune-based diagnosis of tuberculosis. Lancet 356 (2000) 1099-1104
17. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174 (2006) 736-742
18. Farhat M., Greenaway C., Pai M., et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 10 (2006) 1192-1204
19. Joos T.J., Miller W.C., and Murdoch D.M. Tuberculin reactivity in bacille Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis 10 (2006) 883-891
20. Matulis G., Jüni P., Villiger P.M., et al. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases performance of a Mycobacterium tuberculosis antigen specific IFN-gamma assay. Ann Rheum Dis (2007) 10.1136/ard.2007.070789
21. Yew W.W., and Leung C.C. Update in tuberculosis 2006. Am J Respir Crit Care Med 175 (2007) 541-546
22. Pai M., Dheda K., Cunningham J., et al. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 7 (2007) 428-438
23. Pai M., Kalantri S., and Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 6 (2006) 413-422
24. Lambert L., Rajbhandary S., Quails N., et al. Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infect Control Hosp Epidemic 24 (2003) 814-820
25. Diel R., Nienhaus A., Lange C., et al. Cost optimization of screening for latent tuberculosis in close contacts. Eur Respir J 28 (2006) 35-44
26. Wrighton-Smith P., and Zelleweger J.P. Direct costs of three models for screening of latent tuberculosis infection. Eur Respir J 28 (2006) 45-50